Neon Therapeutics, Inc. (NTGN): Price and Financial Metrics


Neon Therapeutics, Inc. (NTGN)

Today's Latest Price: $3.07 USD

0.23 (8.10%)

Updated May 5 7:45pm

Add NTGN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 213 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

NTGN Daily Price Range
NTGN 52-Week Price Range

NTGN Stock Price Chart Technical Analysis Charts


NTGN Price/Volume Stats

Current price $3.07 52-week high $6.25
Prev. close $2.84 52-week low $0.88
Day low $2.91 Volume 3,609,700
Day high $3.09 Avg. volume 516,108
50-day MA $2.26 Dividend yield N/A
200-day MA $2.00 Market Cap 88.93M

Neon Therapeutics, Inc. (NTGN) Company Bio


Neon Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in developing neoantigen-targeted therapies for cancers in the United States. It is developing NEO-PV-01, a neoantigen vaccine that is in Phase Ib clinical trial in combination with nivolumab for the treatment of metastatic melanoma, non-small cell lung cancer, and bladder cancer; NEO-PTC-01, a neoantigen T cell therapy for the treatment of solid tumors; and NEO-SV-01, a neoantigen vaccine for the treatment of estrogen-receptor-positive breast cancer. The company was founded in 2013 and is based in Cambridge, Massachusetts.


NTGN Latest News Stream


Event/TimeNews Detail
Loading, please wait...

NTGN Latest Social Stream


Loading social stream, please wait...

View Full NTGN Social Stream

Latest NTGN News From Around the Web

Below are the latest news stories about Neon Therapeutics Inc that investors may wish to consider to help them evaluate NTGN as an investment opportunity.

Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies – HXL, AMTD, FSB, NTGN

NEW YORK, March 12, 2020 -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders..

Yahoo | March 12, 2020

Lifshitz & Miller LLP Announces Investigation of Neon Therapeutics, Inc., Stein Mart, Inc., and Taubman Centers, Inc.

NEW YORK, March 11, 2020 -- Neon Therapeutics, Inc. (NASDAQ:NTGN) Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with.

Yahoo | March 11, 2020

Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - FSB, NTGN, HXL

NEW YORK, NY / ACCESSWIRE / March 9, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP ...

Yahoo | March 9, 2020

MEET, AMTD, NTGN, and HXL SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers

WILMINGTON, Del., March 09, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: The Meet Group, Inc. (NASDAQ GS: MEET) regarding possible breaches of.

Yahoo | March 9, 2020

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - HXL, NTGN, AMTD

NEW YORK, NY / ACCESSWIRE / March 4, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP ...

Yahoo | March 4, 2020

Read More 'NTGN' Stories Here

NTGN Price Returns

1-mo N/A
3-mo 35.84%
6-mo 157.98%
1-year -28.94%
3-year N/A
5-year N/A
YTD 160.17%
2019 -76.54%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7974 seconds.